Role of MRI in Active Surveillance of Prostate Cancer

被引：0

作者：

Chappidi, Meera R. ^{[1
]}

Lin, Daniel W. ^{[1
]}

Westphalen, Antonio C. ^{[1
,2
,3
]}

机构：

[1] Univ Washington, Sch Med, Dept Urol, Seattle, WA USA

[2] Univ Washington, Sch Med, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA

[3] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA

来源：

SEMINARS IN ULTRASOUND CT AND MRI | 2025年 / 46卷 / 01期

关键词：

CLINICAL STAGE; MEN; BIOPSY; PROGRESSION; OUTCOMES;

D O I：

10.1053/j.sult.2024.11.002

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Magnetic resonance imaging (MRI) plays an important role in the management of patients with prostate cancer on active surveillance. In this review, we will explore the incorporation of MRI into active surveillance protocols, detailing its impact on clinical decision-making and patient management and discussing how it aligns with current guidelines and practice patterns. The role of MRI in this patient population continues to evolve over time, and we will discuss some of the recent advancements in the field and highlight potential areas for future research endeavors.

引用

页码：31 / 44

页数：14

共 50 条

[21] Active surveillance for prostate cancer: the role of the pathologist
Delahunt, Brett
Hammond, Elizabeth
Egevad, Lars
Samaratunga, Hemamali
Srigley, John R.
Humphrey, Peter A.
Rubin, Mark
Epstein, Jonathan I.
Lin, Daniel W.
Gore, John L.
Nacey, John N.
Klotz, Laurence
Sandler, Howard
Zietman, Anthony L.
Holden, Stuart
Montironi, Rodolfo
Evans, Andrew J.
McKenney, Jesse K.
Berney, Dan
Wheeler, Thomas M.
Chinnaiyan, Arul M.
True, Lawrence
Knudsen, Beatrice
Amin, Mahul B.
PATHOLOGY, 2015, 47 (01) : 1 - 3
[22] The Role of Active Surveillance in the Management of Prostate Cancer
Fung-Kee-Fung, Simon D.
Porten, Sima P.
Meng, Maxwell V.
Kuettel, Michael
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (02): : 183 - 187
[23] Imaging in Diagnosis and Active Surveillance for Prostate Cancer
Li, Thomas
Nalavenkata, Sunny
Fainberg, Jonathan
JAMA SURGERY, 2025, 160 (01) : 93 - 99
[24] Update and optimization of active surveillance in prostate cancer
Rubio-Briones, J.
Pastor Navarro, B.
Esteban Escano, L. M.
Borque Fernando, A.
ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (01): : 1 - 7
[25] Role of histopathology and molecular markers in the active surveillance of prostate cancer
Montironi, Rodolfo
Egevad, Lars
Bjartell, Anders
Berney, Daniel M.
ACTA ONCOLOGICA, 2011, 50 : 56 - 60
[26] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Augustin, Herbert
Mayerhofer, Katrin
Seles, Maximilian
Pummer, Karl
UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
[27] Active Surveillance for Prostate Cancer Expanding the Role of MR Imaging and the Use of PRECISE Criteria
Englman, Cameron
Barrett, Tristan
Moore, Caroline M.
Giganti, Francesco
RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (01) : 69 - 92
[28] Repeat multiparametric MRI in prostate cancer patients on active surveillance
Eineluoto, Juho T.
Jarvinen, Petrus
Kenttamies, Anu
Kilpelainen, Tuomas P.
Vasarainen, Hanna
Sandeman, Kevin
Erickson, Andrew
Mirtti, Tuomas
Rannikko, Antti
PLOS ONE, 2017, 12 (12):
[29] Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Shah, Salonee
Beckmann, Kerri
Van Hemelrijck, Mieke
Challacombe, Ben
Popert, Rick
Dasgupta, Prokar
Rusere, Jonah
Zisengwe, Grace
Elhage, Oussama
Santaolalla, Aida
BMC CANCER, 2021, 21 (01)
[30] Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance
Sahibzada, Iqbal
Batura, Deepak
Hellawell, Giles
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (04) : 529 - 533

← 1 2 3 4 5 →